Home   Categories   Grid

Subscribe Now

BenevolentAI aims to enter clinic in 2023 with candidate for novel ulcerative colitis target

BenevolentAI aims to enter clinic in 2023 with candidate for novel ulcerative colitis target

BenevolentAI aims to enter clinic in 2023 with candidate for novel ulcerative colitis target

21 October 2021

The novel biological target identified using AI has been experimentally validated.

1

Illumina offers insight into world of DNA sequencing for 35 interns at Granta Park

Illumina offers insight into world of DNA sequencing for 35 interns at Granta Park

Illumina offers insight into world of DNA sequencing for 35 interns at Granta Park

07 October 2021

They are working alongide industry experts on real-time projects.


‘Ground-breaking’ breast cancer trial results fuel blockbuster drug hopes for AstraZeneca

‘Ground-breaking’ breast cancer trial results fuel blockbuster drug hopes for AstraZeneca

‘Ground-breaking’ breast cancer trial results fuel blockbuster drug hopes for AstraZeneca

01 October 2021

It is working with Daiichi Sankyo on Enhertu.


AstraZeneca to invest in Imperial College London spin-off VaxEquity and build $360m manufacturing facility in Ireland

AstraZeneca to invest in Imperial College London spin-off VaxEquity and build $360m manufacturing facility in Ireland

AstraZeneca to invest in Imperial College London spin-off VaxEquity and build $360m manufacturing facility in Ireland

27 September 2021

VaxEquity could receive up to $195m.


CC Bio aims to improve health of millions of women and cystic fibrosis patients with microbiome editing technology

CC Bio aims to improve health of millions of women and cystic fibrosis patients with microbiome editing technology

CC Bio aims to improve health of millions of women and cystic fibrosis patients with microbiome editing technology

23 September 2021

The company recently secured £890,000 from Cambridge-based CMS Ventures.


AI used to predict Covid-19 patients’ oxygen needs by NVIDIA and hospitals including Addenbrooke’s

AI used to predict Covid-19 patients’ oxygen needs by NVIDIA and hospitals including Addenbrooke’s

AI used to predict Covid-19 patients’ oxygen needs by NVIDIA and hospitals including Addenbrooke’s

23 September 2021

They used federated learning to train an algorithm without sharing data.


Metrion Biosciences plots global growth by doubling its space with new Granta Park headquarters

Metrion Biosciences plots global growth by doubling its space with new Granta Park headquarters

Metrion Biosciences plots global growth by doubling its space with new Granta Park headquarters

23 September 2021

It intends to expand in the US in 2022.


PetMedix closes £27m round close to propel pipeline through the clinic

PetMedix closes £27m round close to propel pipeline through the clinic

PetMedix closes £27m round close to propel pipeline through the clinic

10 September 2021

Two new investors have joined.


AstraZeneca and European Commission end legal dispute over supply of Covid-19 vaccine

AstraZeneca and European Commission end legal dispute over supply of Covid-19 vaccine

AstraZeneca and European Commission end legal dispute over supply of Covid-19 vaccine

10 September 2021

It had been heading for the courts.


Cambridge Clinical Laboratories to offer prostate cancer gene test Prostatype to UK healthcare facilities

Cambridge Clinical Laboratories to offer prostate cancer gene test Prostatype to UK healthcare facilities

Cambridge Clinical Laboratories to offer prostate cancer gene test Prostatype to UK healthcare facilities

01 September 2021

Milton-based CCL has teamed up with Prostatype Genomics.


Excivion confirms success of dengue and Zika antibody tests with ‘invisibility cloak’ technology

Excivion confirms success of dengue and Zika antibody tests with ‘invisibility cloak’ technology

Excivion confirms success of dengue and Zika antibody tests with ‘invisibility cloak’ technology

20 August 2021

The novel tests could be used to inform vaccination practice.


Mission Therapeutics earns $20m milestone payment from AbbVie in Alzheimer’s and Parkinson’s collaboration

Mission Therapeutics earns $20m milestone payment from AbbVie in Alzheimer’s and Parkinson’s collaboration

Mission Therapeutics earns $20m milestone payment from AbbVie in Alzheimer’s and Parkinson’s collaboration

11 August 2021

Two targets have been identified.

4

Maggot enzyme in wound-cleaning product Aurase powers Cambridge biotech start-up SolasCure to £15m Series A raise

Maggot enzyme in wound-cleaning product Aurase powers Cambridge biotech start-up SolasCure to £15m Series A raise

Maggot enzyme in wound-cleaning product Aurase powers Cambridge biotech start-up SolasCure to £15m Series A raise

10 August 2021

Industry veterans have backed the company.


Stemnovate raises more than £1m to expand commercialisation of its drug discovery and diagnostic technology

Stemnovate raises more than £1m to expand commercialisation of its drug discovery and diagnostic technology

Stemnovate raises more than £1m to expand commercialisation of its drug discovery and diagnostic technology

05 August 2021

The company is already with pharma and universities.


Cambridge neuroscience specialist NRG Therapeutics secures $500,000 Parkinson’s research grant

Cambridge neuroscience specialist NRG Therapeutics secures $500,000 Parkinson’s research grant

Cambridge neuroscience specialist NRG Therapeutics secures $500,000 Parkinson’s research grant

04 August 2021

It is plotting a Series A funding round.

3

Mestag Therapeutics extends seed round to $45m

Mestag Therapeutics extends seed round to $45m

Mestag Therapeutics extends seed round to $45m

03 August 2021

The immuno-oncology and inflammatory disease specialist is targeting activated fibroblast populations.


‘A revolution for life sciences’ - DeepMind and EMBL-EBI release database of human protein structures

‘A revolution for life sciences’ - DeepMind and EMBL-EBI release database of human protein structures

‘A revolution for life sciences’ - DeepMind and EMBL-EBI release database of human protein structures

29 July 2021

It will lead to new treatments for disease.


Artios secures £110m to progress its cancer-killing DDR platform

Artios secures £110m to progress its cancer-killing DDR platform

Artios secures £110m to progress its cancer-killing DDR platform

28 July 2021

The oversubscribed round was co-led by Omega Funds and TCG X.


Biofidelity confirms scientific advisory board as it heads towards launch of ASPYRE-Lung diagnostic test

Biofidelity confirms scientific advisory board as it heads towards launch of ASPYRE-Lung diagnostic test

Biofidelity confirms scientific advisory board as it heads towards launch of ASPYRE-Lung diagnostic test

28 July 2021

It includes pharma leaders and patient advocates.


University of Cambridge Enterprize Zone draws up roadmap for strengthening positioning as global healthtech leader

University of Cambridge Enterprize Zone draws up roadmap for strengthening positioning as global healthtech leader

University of Cambridge Enterprize Zone draws up roadmap for strengthening positioning as global healthtech leader

23 July 2021

Connect: Health Tech suggest how cultural, financial and geographical challenges can be overcome.


This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More